MB-22 CHECKPOINT KINASE 1 EXPRESSION IS AN ADVERSE PROGNOSTIC MARKER AND THERAPEUTIC TARGET IN MYC-DRIVEN MEDULLOBLASTOMA

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Prince, Eric, Shah, Monil, Venkataraman, Sujatha, Balakrishnan, Ilango, Alimova, Irina, Harris, Peter, Birks, Diane, Donson, Andrew, Taylor, Michael, Handler, Michael, Foreman, Nicholas, Vibhakar, Rajeev
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2015
Materias:
Abstracts from the 3rd Biennial Conference on Pediatric Neuro-Oncology Basic and Translational Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4483034/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov061.98
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares